The United States has become a hub for commercial surrogacy, egg sales, and pre-selection of embryos, fueled by factors like access to Harvard and a desire for “ideal” traits. This burgeoning market allows individuals to purchase reproductive services, raising concerns about the commodification of the human body. Critics argue that these practices, framed as reproductive freedom, border on eugenics by allowing for the selection of preferred characteristics. The high demand and available technology are driving up prices within the industry. This has led to considerable ethical debate regarding the implications of turning reproduction into a commercial transaction and the potential consequences for future generations. The practice highlights a stark contrast in perspectives on reproductive rights and the value placed on genetic traits.